Cooper Companies, Inc. (The) (COO) Issues FY17 Earnings Guidance

Cooper Companies, Inc. (The) (NYSE:COO) updated its FY17 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $9.66-9.76 for the period, compared to the Thomson Reuters consensus estimate of $9.63. The company issued revenue guidance of $2.13-2.14 billion, compared to the consensus revenue estimate of $2.13 billion.Cooper Companies, Inc. (The) also updated its Q4 guidance to $2.60-2.70 EPS.

Several analysts have recently commented on the stock. Piper Jaffray Companies raised their price objective on shares of Cooper Companies, Inc. (The) to $265.00 and gave the company an overweight rating in a research report on Wednesday, July 19th. BidaskClub downgraded shares of Cooper Companies, Inc. (The) from a strong-buy rating to a buy rating in a report on Tuesday, July 25th. Jefferies Group LLC reiterated a buy rating and issued a $250.00 price target on shares of Cooper Companies, Inc. (The) in a report on Tuesday. Stephens reiterated an equal weight rating and issued a $250.00 price target (up from $235.00) on shares of Cooper Companies, Inc. (The) in a report on Tuesday. Finally, Zacks Investment Research downgraded shares of Cooper Companies, Inc. (The) from a buy rating to a hold rating in a report on Thursday, June 22nd. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus price target of $257.60.

Shares of Cooper Companies, Inc. (COO) opened at 247.00 on Friday. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The stock has a 50 day moving average of $245.27 and a 200-day moving average of $224.26. The company has a market capitalization of $12.07 billion, a P/E ratio of 37.03 and a beta of 0.59.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating the Zacks’ consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million during the quarter, compared to analysts’ expectations of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.30 earnings per share. Equities research analysts forecast that Cooper Companies, Inc. will post $9.72 EPS for the current year.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel G. Mcbride sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, June 21st. The stock was sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the sale, the chief operating officer now owns 34,395 shares of the company’s stock, valued at $8,400,290.85. The disclosure for this sale can be found here. Insiders sold 20,992 shares of company stock valued at $5,167,628 over the last quarter. Company insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was first posted by BBNS and is the property of of BBNS. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://baseballnewssource.com/markets/cooper-companies-inc-the-coo-updates-fy17-earnings-guidance/1565109.html.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.